Synageva BioPharma Nabs $30M

Xconomy Boston — 

Synageva BioPharma, a Waltham, MA-based biotech firm with research and manufacturing operations in Athens, GA, says that it has closed a $30 million private equity financing and expects to raise more money in the weeks ahead. Baker Brothers Investments, a heathcare investment firm, led the financing, which included contributions from investment funds Tullis Dickerson and Four Partners. Synageva says that it is developing novel protein drugs and follow-on biologics, which are intended to be copies of existing biotech drugs.